Figure 5 shows that tumors from the SNU308-LCN2si cell group had a much lower tumor weight and smaller tumor volume than that in the SNU308-COLsi cell group, indicating that LCN2 knockdown was able to inhibit CCA cell growth in vivo. This evidence concerns the gene LCN2 and cholangiocarcinoma.